RLMD
Relmada Therapeutics, Inc. · Healthcare
CFO Maged Shenouda sold $355K of Relmada Therapeutics, Inc.
Sold$354,507
$35.45Price
10,000Shares
−82%Stake
What RLMD did after the filing
- The stock from Wed, Mar 10 close, $34.87
- +6.3%
- S&P 500, same days
- +6.2%
Measured over 30 trading days, to the Apr 22 close.
Traded Mon, Mar 8. Filed Wed, Mar 10, 1:18 PM ET, during the session. Returns use the Mar 10 close and the Apr 22 close. Not investment advice.